Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 916 publications

Primary large B-cell lymphoma of the central nervous system mimicking inflammatory myelitis at initial presentation.

Primary large B-cell lymphoma of the central nervous system mimicking inflammatory myelitis at initial presentation.

Journal: Journal of clinical and experimental hematopathology : JCEH
Published: November 30, 2025

Ofatumumab for the management of refractory pemphigus vulgaris: A case series.

Ofatumumab for the management of refractory pemphigus vulgaris: A case series.

Journal: JAAD international
Published: October 24, 2025

Ofatumumab-mediated CD20+ B-cell depletion promotes neuromuscular junction functional recovery and sustains long-term efficacy in refractory generalized myasthenia gravis.

Ofatumumab-mediated CD20+ B-cell depletion promotes neuromuscular junction functional recovery and sustains long-term efficacy in refractory generalized myasthenia gravis.

Journal: Frontiers in pharmacology
Published: October 20, 2025

Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies.

Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies.

Journal: Expert opinion on drug safety
Published: October 13, 2025

Concomitant treatment of secukinumab and ofatumumab in a psoriasis patient with multiple sclerosis.

Concomitant treatment of secukinumab and ofatumumab in a psoriasis patient with multiple sclerosis.

Journal: Italian journal of dermatology and venereology
Published: October 01, 2025

Tumefactive demyelinating lesion during B-cell depletion therapy by ofatumumab.

Tumefactive demyelinating lesion during B-cell depletion therapy by ofatumumab.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 30, 2025

Multiple sclerosis pathophysiology: a comprehensive review of genetic, environmental, and immunological drivers.

Multiple sclerosis pathophysiology: a comprehensive review of genetic, environmental, and immunological drivers.

Journal: Inflammopharmacology
Published: September 23, 2025

A Case of Severe Bilateral Optic Neuritis and a Tumefactive Demyelinating Lesion in Pregnancy.

A Case of Severe Bilateral Optic Neuritis and a Tumefactive Demyelinating Lesion in Pregnancy.

Journal: Internal medicine (Tokyo, Japan)
Published: September 18, 2025

Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis.

Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis.

Journal: Multiple sclerosis and related disorders
Published: September 03, 2025

Monoclonal Antibodies as a Breakthrough in Personalised Leukaemia Therapy: What Pharmacists and Doctors Should Know.

Monoclonal Antibodies as a Breakthrough in Personalised Leukaemia Therapy: What Pharmacists and Doctors Should Know.

Journal: Pharmacy (Basel, Switzerland)
Published: August 31, 2025

Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple sclerosis)

Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple sclerosis)

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 08, 2025

Combination therapy of ofatumumab and daratumumab in patients with severe anti-NMDA receptor encephalitis.

Combination therapy of ofatumumab and daratumumab in patients with severe anti-NMDA receptor encephalitis.

Journal: Frontiers in immunology
Published: August 08, 2025
Showing 1-12 of 916

Last Updated: 01/07/2026